Federal Project Grant Award Summary The University of Utah, through its Office of Sponsored Projects Division, received a $201,960 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective July 1, 2026, through June 30, 2031. This five-year award funds a mixed-methods feasibility trial investigating transcranial magnetic stimulation (TMS) as a therapeutic intervention for methamphetamine use disorder (MAUD)...
Summary The National Institute on Drug Abuse (NIDA) awarded $2.31 million to the University of California, San Diego under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025, through April 30, 2030. This Project Grant funds a hybrid Type I implementation trial titled "Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening," which addresses the intersecting epidemics of HIV and substance use...
Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,624 Project Grant to The Johns Hopkins University, effective April 15, 2026 through March 31, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This K01 Career Development Award supports research aimed at identifying and leveraging social network dynamics to improve treatment engagement and health outcomes for parents who misuse opioids and have dependent children (PWUO-DC). The project...
Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $438,854 Project Grant to the University of California, San Diego, effective August 1, 2025, through July 31, 2027, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research initiative will generate longitudinal data and qualitative insights on social isolation and loneliness trajectories among older adults living with HIV who use methamphetamine. The study will recruit a baseline cohort of...
Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded SUNY Downstate Health Sciences University a $6.94 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal investigation of neighborhood conditions, neural circuits, and substance use behaviors across the early life course. The award, effective September 30, 2025, through June 30, 2029, addresses the multifactorial etiology of substance use disorders...
Summary of Federal Project Grant Award Brown University received a $159,500 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 15, 2026, with completion targeted for April 30, 2028. The grant funds a pilot research study investigating how drug use network characteristics influence utilization of overdose prevention programs among people who use unregulated drugs in Rhode Island. Nested within an ongoing...
Federal Project Grant Award Summary The University of Utah received a $462,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective June 1, 2026 through April 30, 2031. This award funds research to develop novel photochemical tools for precision control of neuropeptide modulation in methamphetamine use disorder withdrawal. The project will engineer a modular library of cyclic, photolabile caging scaffolds to...
Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $1,458,907 to the University of California, San Francisco on August 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal study examining the relationship between adolescent social media use and substance use. The project, titled "Longitudinal Pathways Between Adolescent Social Media Use and Substance Use: Informing Evidence-Based Guidance," will leverage data...
Federal Grant Award Summary The University of Virginia received an $800,105 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to optimize a digital intervention addressing alcohol-exposed pregnancy (AEP) risk in Native women and communities. Awarded September 20, 2025, with completion targeted for August 31, 2028, this research initiative will tailor and systematically test the CARRII digital...
Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $439,500 to the University of California, San Diego under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate a novel research paradigm for studying family dynamics in adolescent substance use. The project, initiated March 1, 2026 and concluding February 29, 2028, will produce a methodological framework that shifts from traditional cross-sectional survey approaches to real-time,...
Summary
The University of Utah received a $154,536 Project Grant award dated August 20, 2026, from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal social network analysis research on Native American mothers navigating substance use disorder (SUD) in partnership with the Confederated Tribes of the Goshute Reservation. The project, titled "Relations and Recovery: A Social Network Analysis of Native Mothers Navigating Substance Use," will characterize the social networks of Native mothers participating in CEREMONY, a culturally integrated perinatal clinical program designed to address SUD and related maternal health outcomes. The research deliverables include comprehensive documentation of how social network characteristics correlate with SUD recovery and perinatal program outcomes, along with qualitative analysis of participants' perceptions regarding the impact of their social networks on health behaviors and recovery trajectories.
The project addresses a documented gap in understanding how traditional kinship structures and community healing practices among Native Americans influence substance use recovery and maternal health outcomes—areas with significant disparities in mortality and morbidity. Through mixed-methods analysis extending through February 28, 2030, the research will generate empirical evidence to inform the development and refinement of culturally responsive interventions for pregnant and postpartum Native American women with SUD, ultimately contributing to the National Institute on Drug Abuse's mission to advance prevention, diagnosis, and treatment approaches for substance use disorders.